Cart
sales@molnova.com
20(R)-Notoginsenoside R2
CAS No. 948046-15-9
20(R)-Notoginsenoside R2( —— )
Catalog No. M31437 CAS No. 948046-15-9
20(R)-Notoginsenoside R2 is a natural product with Promote blood circulation and improve myocardial ischemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 209 | In Stock |
|
| 10MG | 309 | In Stock |
|
| 25MG | 521 | In Stock |
|
| 50MG | 733 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name20(R)-Notoginsenoside R2
-
NoteResearch use only, not for human use.
-
Brief Description20(R)-Notoginsenoside R2 is a natural product with Promote blood circulation and improve myocardial ischemia.
-
Description20(R)-Notoginsenoside R2 is a natural product with Promote blood circulation and improve myocardial ischemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number948046-15-9
-
Formula Weight771
-
Molecular FormulaC41H70O13
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Growth Hormone Relea...
Growth Hormone Releasing Factor, GRF (1 - 40), amide, human
-
Vopratelimab
Vopratelimab (JTX-2011) is a selective humanized immunoglobulin G1-kappa monoclonal antibody and a potent ICOS agonist with high affinity for inducible T cell co-stimulating factors (ICOS), showing affinities of 0.93 nM for hICOS, 3.7 nM for rat ICOS, and 0.64 nM for mICOS.
-
Inotuzumab
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22.
